Skip to main content
. 2019 May 14;68(7):1087–1094. doi: 10.1007/s00262-019-02344-6

Table 2.

CTC detection rate and PD-L1% in treatment-naïve NSCLC patients

All patients Early stage (stages 1–2) Advanced stage (stages 3–4) Unknown stage
Subject # 49 24 23 2
CTC detection (≥1 CTC/2 mL) 42 (86%) 21 (88%) 20 (87%) 1 (50%)
PD-L1(+) CTC 28 (67%) 12 (57%) 16 (80%) 0
PD-L1(−) CTC 14 (33%) 9 (43%) 4 (20%) 1 (100%)